Welch & Forbes’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,800
Closed -$471K 386
2024
Q3
$471K Sell
9,800
-1,200
-11% -$57.8K 0.01% 295
2024
Q2
$546K Hold
11,000
0.01% 273
2024
Q1
$597K Sell
11,000
-1,200
-10% -$62.6K 0.01% 270
2023
Q4
$687K Sell
12,200
-82
-0.7% -$4.63K 0.01% 255
2023
Q3
$759K Sell
12,282
-1,850
-13% -$117K 0.01% 241
2023
Q2
$834K Buy
14,132
+126
+0.9% +$8.02K 0.01% 242
2023
Q1
$1.03M Buy
14,006
+6
+0% +$463 0.02% 228
2022
Q4
$1.02M Hold
14,000
0.02% 228
2022
Q3
$1.17M Hold
14,000
0.02% 202
2022
Q2
$1.12M Buy
14,000
+8,000
+133% +$777K 0.02% 213
2022
Q1
$624K Buy
+6,000
New +$497K 0.01% 272

Other funds holding NTR

Welch & Forbes's NTR Position: Q4 2024 in Review

Welch & Forbes sold out of Nutrien (NTR) in Q4 2024, closing a stake of 9,800 shares — an estimated $471K sold.

Welch & Forbes first reported a position in NTR in Q1 2022 and held it in 11 quarters. The position peaked at $1.17M in Q3 2022. 593 funds tracked by Wall St. Rank hold NTR as of Q4 2024.

  • Welch & Forbes reported no remaining Nutrien position as of Q4 2024 after selling out during the quarter.
  • Welch & Forbes sold 9,800 Nutrien shares in Q4 2024, an estimated $471K.
  • Welch & Forbes first reported a position in Nutrien in Q1 2022 and held it in 11 quarters.
  • Welch & Forbes's Nutrien position peaked at $1.17M in Q3 2022.
  • 593 funds tracked by Wall St. Rank held Nutrien as of Q4 2024.

Based on Welch & Forbes's 13F filing for Q4 2024, filed 7 Feb 2025.